NCT03830723View on ClinicalTrials.gov

Personalized Insemination Treatment Study

PHASE2CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

January 20, 2021

Study Completion Date

September 27, 2021

Conditions

InfertilityIntrauterine InseminationReproduction

Interventions

DRUG

Follitropin delta

Study medication doses during all 3 insemination will be personalized using a suggested algorithm

Trial Locations (1)

H4P 2S4

Clinique Ovo, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Clinique Ovo

INDUSTRY

NCT03830723 - Personalized Insemination Treatment Study | Biotech Hunter | Biotech Hunter